Xuanzhu Biopharmaceutical Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2021	FY 2020
Period Ending	Apr '26 Apr 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	17,382	36,515	-	-	-	-
Enterprise Value	16,657	36,396	-	-	-	-
Last Close Price	33.56	70.50	-	-	-	-
PS Ratio	301.71	633.81	-	-	-	-
PB Ratio	11.40	23.95	-	-	-	-
P/TBV Ratio	15.12	31.77	-	-	-	-
EV/Sales Ratio	289.13	631.74	-	-	-	-
Debt / Equity Ratio	0	0	0.00	0.02	0.02	0
Net Debt / Equity Ratio	-0.48	-0.48	-0.26	-0.39	-0.68	-0.71
Net Debt / EBITDA Ratio	3.42	3.42	0.46	1.37	3.02	4.29
Net Debt / FCF Ratio	-	-	1.92	3.68	2.47	3.62
Asset Turnover	0.04	0.04	0.02	-	-	-
Inventory Turnover	0.26	0.26	0.25	-	-	-
Quick Ratio	3.01	3.01	1.45	3.24	19.95	14.26
Current Ratio	3.75	3.75	2.06	3.79	21.28	14.95
Return on Equity (ROE)	-21.10%	-21.10%	-53.84%	-	-29.47%	-16.87%
Return on Assets (ROA)	-9.60%	-9.60%	-27.97%	-	-15.83%	-14.54%
Return on Capital Employed (ROCE)	-15.40%	-15.40%	-55.40%	-28.80%	-23.00%	-17.70%
Earnings Yield	-1.57%	-0.75%	-	-	-	-
Buyback Yield / Dilution	-3.15%	-3.15%	-	-14.22%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.